The importance of using tools beyond lifestyle in managing obesity

    Goodfellow Symposium
    Sunday 25 March 2018

    Presentation by:

    Professor John Dixon, Head of clinical obesity research at the Baker Heart and Diabetes Institute in Melbourne, Australia.

    In this Breakfast Symposium, Professor John Dixon focused on the importance of tools such as pharmacotherapy, meal replacements and bariatric surgery, as lifestyle enablers, in the management of obesity, a disease he notes should be approached in the same manner as other chronic illnesses.

    IBD in Primary Care – Practical Management Tips

    GPCME 2018 - Rotorua
    Saturday June 9, 2018

    Presentation by:
    Dr David Rowbotham
    Consultant Gastroenterologist, Department of Gastroenterology and Hepatology, Auckland Hospital

    In this workshop held at GPCME 2018, Dr David Rowbotham presented tips for primary care clinicians on the best approaches to managing IBD patients in everyday practice.  He also discussed some novel therapies, stopping treatment and the IBD clinical trials taking place at the Auckland District Health Board.
     
    The video production for this presentation was funded by Emerge Health.

    Breakfast Session - Shared Care of the IBD Patient

    GPCME 2018 - Rotorua
    Sunday  June 10, 2018

    Presentations by:
    Drs Rick Stein and Ali Jafer (Consultant Gastroenterologists)
    Phoebe Wu and Jacqui Fletcher (IBD Nurses)

    In this Breakfast Session held at GPCME 2018, Dr Rick Stein discussed the growing burden of IBD in NZ.
     
    Dr Ali Jafer and Phoebe Wu also presented on the value of and models for shared care for the IBD patient, and Jacqui Fletcher gave tips for primary care clinicians on the best approaches to managing IBD patients.
     
    The video production for this presentation was funded by Emerge Health.

    Curing Hepatitis C in Primary Care

    GPCME 2019 - Rotorua
    Saturday June 22, 2019

    Presentation by:
    Dr Alex Lampen-Smith
    Gastroenterologist and Hepatologist at the Bay of Plenty District Health Board, and Clinical Director of the Hepatitis Foundation of New Zealand.

    In this breakfast symposium held at GPCME 2019, Dr Alex Lampen-Smith presented risk factors associated with Hepatitis C (HCV), barriers to identifying the disease and pre-treatment assessment of patients with HCV.  She also introduced the funded HCV therapy Maviret® and discussed its use, illustrated by a number of case studies.

    The video production for this presentation was funded by Abbvie.

    Insulin initiation, titration and escalation: A practical guide for busy clinicians in primary care

    Webinar - October 2019

    Presentation by:
    Carl Peters
    Endocrinologist, North Shore Hospital

    In this webinar, Dr Carl Peters provided clinicians with a practical guide to the use of insulin in patients with type 2 diabetes mellitus.

    GORD – How to Optimise Management

    Presented by Gastroenterologist Alasdair Patrick

    Extended Prevention of Recurrent VTE

    Speaker: Dr Gordon Royle

    In this recording of a live webcast event held in August 2020, Dr Royle addressed an audience of GPs and nurse practitioners on extended prevention of recurrent venous thromboembolism in primary care with a focus on the recommendations in the THANZ 2019 VTE Guidelines.

    Gordon Royle is a graduate of Otago Medical School. After moving to Auckland he undertook a Masters in Molecular Biology, and went on to train in Haematology. For the last 19 years he has been working as a Haematologist and researcher at Middlemore Hospital, and is a senior lecturer at Auckland University's School of Medicine. A particular interest is Coagulation Haematology. His clinical research experience includes the role of PI in several new oral anticoagulant trials. Prior research experience includes seven years' molecular biology in the USA including two years at The Salk Institute.

    The Elimin8 Educational Series on Hepatitis C - Benefits of a Cure

    This is the first in a series of audio podcasts on the elimination of Hepatitis C in NZ.

    In this podcast Assoc Professor Catherine Stedman discusses the benefits of curing Hepatitis C.

    We also hear from a patient about their personal experience of living with, and being cured of, the Hepatitis C virus.

    Associate Professor Stedman is a specialist Gastroenterologist and Hepatologist at Christchurch Hospital, and also works as a Clinical Senior Lecturer for the University of Otago where she convenes medical student gastroenterology teaching.

    Her field of research is liver disease and pharmacology, focusing on hepatitis C and autoimmune liver diseases. Her published papers in hepatitis C epidemiology have influenced global understanding of chronic hepatitis C epidemiology including government and Ministry of Health understanding and approach to hepatitis C treatment strategies.

    The audio production for this presentation was funded by Abbvie.  
     

    The Elimin8 Educational Series on Hepatitis C - Testing and Treatment

    This is the second in a series of audio podcasts on the elimination of Hepatitis C in NZ.    

    In this podcast we hear from Dr Homie Razavi, Associate Professor Catherine Stedman and Judith McLaughlin, Hepatitis Nurse Specialist, on testing and treating the Hepatitis C virus. We also hear from a patient about their personal experience of being diagnosed with Hepatitis C.

    The audio production for this presentation was funded by Abbvie.  
     

    The Elimin8 Educational Series on Hepatitis C - Treatment in Primary Care

    This is the third in a series of audio podcasts on the elimination of Hepatitis C in NZ. 

    In this podcast we hear from Dr John Cameron, a GP based in Auckland, who moves through the Hepatitis C Care Cascade using his own patient case study. 

    In this very informative interview Dr Cameron provides practical, down to earth advice to his GP colleagues on how to approach their patients with HCV, and how to help them deal with the stigma associated with this disease.

    The audio production for this presentation was funded by Abbvie.  
     

    The ElimIn8 Educational Series on Hepatitis C - A virus we can cure

    Welcome to the ElimIn8 Educational Series on Hepatitis C - A virus we can cure*.

    The series consists of three, short audio podcasts where health professionals discuss the role of primary care in  the elimination of Hepatitis C from New Zealand.

    *Cure means no detectable HCV RNA is found in a blood test taken 12 weeks after treatment has finished.

    The audio production for this presentation was funded by Abbvie.